GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Other Operating Expense

Ipca Laboratories (BOM:524494) Other Operating Expense : ₹37,144 Mil (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Other Operating Expense?

Ipca Laboratories's Other Operating Expense for the three months ended in Dec. 2023 was ₹11,241 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹37,144 Mil.

Ipca Laboratories's quarterly Other Operating Expense increased from Jun. 2023 (₹8,339 Mil) to Sep. 2023 (₹11,255 Mil) but then declined from Sep. 2023 (₹11,255 Mil) to Dec. 2023 (₹11,241 Mil).

Ipca Laboratories's annual Other Operating Expense increased from Mar. 2021 (₹17,979 Mil) to Mar. 2022 (₹21,127 Mil) and increased from Mar. 2022 (₹21,127 Mil) to Mar. 2023 (₹24,161 Mil).


Ipca Laboratories Other Operating Expense Historical Data

The historical data trend for Ipca Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Other Operating Expense Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,720.10 16,836.70 17,979.10 21,127.10 24,160.90

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,348.80 6,309.30 8,339.00 11,254.50 11,240.80

Ipca Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹37,144 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ipca Laboratories Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines